A Multicenter Real-World Study Evaluating the Hepatoprotective Effect of Polyene Phosphatidylcholine Against Chronic Hepatitis B
BackgroundPolyene phosphatidylcholine (PPC) has been widely used to treat liver diseases in China. However, there is a lack of post-marketing evidence demonstrating its liver-protective efficiency among patients infected with hepatitis B virus (HBV). This study analyzed the multicenter real-world da...
Main Authors: | Jinghang Xu, Yanan Fan, Yanyan Yu, Yifan Han, Qian Kang, Ning Tan, Yuqing Yang, Hongyu Chen, Jiali Pan, Xiaoyuan Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.842098/full |
Similar Items
-
Polyene phosphatidylcholine enhances the therapeutic response of oxaliplatin in gastric cancer through Nrf2/HMOX1 mediated ferroptosis
by: Peijie Lei, et al.
Published: (2024-05-01) -
Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
by: Yu-Chan Yang, et al.
Published: (2021-12-01) -
Editorial: The role of novel hepatitis B biomarkers in solving therapeutic dilemmas
by: Ivana Lazarevic, et al.
Published: (2023-07-01) -
The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysis
by: Georgia Zeng, et al.
Published: (2024-01-01) -
METTL16 regulates m6A methylation on chronic hepatitis B associated gene HLA-DPB1 involved in liver fibrosis
by: Haibing Gao, et al.
Published: (2022-11-01)